Ivabradine HCl: A Key Intermediate for Chronic Angina and Heart Failure Management
Enhance cardiovascular therapies with our high-purity, GMP-certified Ivabradine HCl pharmaceutical intermediate.
Get a Quote & SampleProduct Core Value
Ivabradine HCl
Ivabradine HCl is a highly specialized pharmaceutical intermediate vital for developing treatments for chronic heart conditions. As a specific sinoatrial If channel inhibitor, it uniquely targets cardiac pacemaker cells, effectively lowering heart rate without compromising myocardial contractility or blood pressure. This mechanism is crucial for managing patients with chronic heart failure and those who cannot tolerate traditional beta-blockers, significantly reducing the risk of cardiovascular mortality and hospital admissions.
- Leverage Ivabradine HCl for chronic angina management, offering a targeted approach to symptom relief and improved quality of life.
- Benefit from high purity Ivabradine HCl, ensuring the efficacy and safety of your final pharmaceutical products.
- Utilize a heart failure intermediate GMP certified, guaranteeing adherence to the highest manufacturing standards for global markets.
- Incorporate a sinoatrial If channel inhibitor into your drug development pipeline to address critical cardiac unmet needs.
Advantages Delivered
Targeted Heart Rate Reduction
Our Ivabradine HCl provides a precise method to reduce heart rate, a critical factor in managing conditions like chronic angina.
Enhanced Patient Outcomes
By helping to reduce the risk of cardiovascular death and hospitalization for heart failure, this intermediate contributes to better patient health.
High Purity and Quality Assurance
With purity exceeding 99%, our product ensures consistent performance and reliability in pharmaceutical formulations, supporting your drug development goals.
Key Applications
Heart Failure Treatment
This pharmaceutical intermediate is instrumental in creating medications to treat heart failure with reduced ejection fraction (HFrEF), improving cardiac function.
Chronic Stable Angina Management
Utilize Ivabradine HCl for chronic angina management, offering a solution for patients requiring effective heart rate control.
Sinus Tachycardia Control
The sinoatrial If channel inhibitor properties make it ideal for controlling sinus tachycardia and other heart rate irregularities.
Post-Myocardial Infarction Care
An essential component for drugs aimed at managing cardiac dysfunction following myocardial infarction, promoting recovery.